Improve Warfarin Therapy or Use Dabigatran for Patients with Atrial Fibrillation - A Cost-Effectiveness Analysis

被引：0
|
作者：
You, Joyce H. [1 ]
Tsui, Kia K. [1 ]
Wong, Raymond S.
Cheng, Gregory
机构：
[1] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [21] Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups
    Clemens, Andreas
    Peng, Siyang
    Brand, Sarah
    Brueckmann, Martina
    Kansal, Anuraag
    Lim, Jonathan
    Noack, Herbert
    Sander, Stephen
    Sorensen, Sonja
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (06): : 849 - 855
  • [22] A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
    Sorensen, Sonja V.
    Peng, Siyang
    Monz, Brigitta U.
    Bradley-Kennedy, Carole
    Kansal, Anuraag R.
    PHARMACOECONOMICS, 2013, 31 (07) : 589 - 604
  • [23] A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
    Sonja V. Sorensen
    Siyang Peng
    Brigitta U. Monz
    Carole Bradley-Kennedy
    Anuraag R. Kansal
    PharmacoEconomics, 2013, 31 : 589 - 604
  • [24] COST EFFECTIVENESS OF APIXABAN, DABIGATRAN RIVAROXABAN AND WARFARIN FOR ATRIAL FIBRILLATION IN GUATEMALA
    Garita, M.
    Peralta, M.
    Gordillo, D., I
    VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [25] Cost-effectiveness of warfarin pharmacogenomics in atrial fibrillation.
    Leey, J.
    McCabe, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S146 - S146
  • [26] Cost-Effectiveness of Genotype-Guided Warfarin Therapy for Anticoagulation in Elderly Patients With Atrial Fibrillation
    Leey, Julio A.
    McCabe, Steve
    Koch, Jennifer A.
    Miles, Toni P.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (04): : 197 - 203
  • [27] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
    Kamel, Hooman
    Johnston, S. Claiborne
    Easton, J. Donald
    Kim, Anthony S.
    STROKE, 2012, 43 (03) : 881 - +
  • [28] COST-EFFECTIVENESS OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN CHINA
    Wan, Y.
    Davies, G. M.
    Lu, Z. G.
    Chen, F.
    Chen, J.
    VALUE IN HEALTH, 2014, 17 (03) : A114 - A114
  • [29] Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
    Pletscher, Mark
    Plessow, Rafael
    Eichler, Klaus
    Wieser, Simon
    SWISS MEDICAL WEEKLY, 2013, 143
  • [30] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Clinical Drug Investigation, 2014, 34 : 9 - 17
12345